Endologix Sees Q4 Sales $32.5M-35.5M vs $35.51M Est

Endologix (NASDAQ:ELGX) sees Q4 sales of $32.5 million-35.5 million vs $35.51 million estimate.

Benzinga · 11/06/2019 21:59

Endologix (NASDAQ:ELGX) sees Q4 sales of $32.5 million-35.5 million vs $35.51 million estimate.